280 related articles for article (PubMed ID: 19115380)
1. Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease.
Sagredo O; González S; Aroyo I; Pazos MR; Benito C; Lastres-Becker I; Romero JP; Tolón RM; Mechoulam R; Brouillet E; Romero J; Fernández-Ruiz J
Glia; 2009 Aug; 57(11):1154-67. PubMed ID: 19115380
[TBL] [Abstract][Full Text] [Related]
2. Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.
Valdeolivas S; Satta V; Pertwee RG; Fernández-Ruiz J; Sagredo O
ACS Chem Neurosci; 2012 May; 3(5):400-6. PubMed ID: 22860209
[TBL] [Abstract][Full Text] [Related]
3. Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile.
Gómez-Cañas M; Morales P; García-Toscano L; Navarrete C; Muñoz E; Jagerovic N; Fernández-Ruiz J; García-Arencibia M; Pazos MR
Pharmacol Res; 2016 Aug; 110():205-215. PubMed ID: 27013280
[TBL] [Abstract][Full Text] [Related]
4. Effects of cannabinoids in the rat model of Huntington's disease generated by an intrastriatal injection of malonate.
Lastres-Becker I; Bizat N; Boyer F; Hantraye P; Brouillet E; Fernández-Ruiz J
Neuroreport; 2003 May; 14(6):813-6. PubMed ID: 12858038
[TBL] [Abstract][Full Text] [Related]
5. Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.
Palazuelos J; Aguado T; Pazos MR; Julien B; Carrasco C; Resel E; Sagredo O; Benito C; Romero J; Azcoitia I; Fernández-Ruiz J; Guzmán M; Galve-Roperh I
Brain; 2009 Nov; 132(Pt 11):3152-64. PubMed ID: 19805493
[TBL] [Abstract][Full Text] [Related]
6. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
Gómez-Gálvez Y; Palomo-Garo C; Fernández-Ruiz J; García C
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():200-8. PubMed ID: 25863279
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG.
Valdeolivas S; Pazos MR; Bisogno T; Piscitelli F; Iannotti FA; Allarà M; Sagredo O; Di Marzo V; Fernández-Ruiz J
Cell Death Dis; 2013 Oct; 4(10):e862. PubMed ID: 24136226
[TBL] [Abstract][Full Text] [Related]
8. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
[TBL] [Abstract][Full Text] [Related]
9. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively.
Alfinito PD; Wang SP; Manzino L; Rijhsinghani S; Zeevalk GD; Sonsalla PK
J Neurosci; 2003 Nov; 23(34):10982-7. PubMed ID: 14645494
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor agonists mediate neuroprotection in malonate-induced striatal lesion in the rat.
Armentero MT; Fancellu R; Nappi G; Blandini F
Exp Neurol; 2002 Dec; 178(2):301-5. PubMed ID: 12504889
[TBL] [Abstract][Full Text] [Related]
11. Protection of malonate-induced GABA but not dopamine loss by GABA transporter blockade in rat striatum.
Zeevalk GD; Manzino L; Sonsalla PK
Exp Neurol; 2002 Jul; 176(1):193-202. PubMed ID: 12093096
[TBL] [Abstract][Full Text] [Related]
12. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid CB2 receptor stimulation attenuates brain edema and neurological deficits in a germinal matrix hemorrhage rat model.
Tao Y; Tang J; Chen Q; Guo J; Li L; Yang L; Feng H; Zhu G; Chen Z
Brain Res; 2015 Mar; 1602():127-35. PubMed ID: 25625355
[TBL] [Abstract][Full Text] [Related]
14. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.
Xia XG; Schmidt N; Teismann P; Ferger B; Schulz JB
J Neurochem; 2001 Oct; 79(1):63-70. PubMed ID: 11595758
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease.
Toulmond S; Tang K; Bureau Y; Ashdown H; Degen S; O'Donnell R; Tam J; Han Y; Colucci J; Giroux A; Zhu Y; Boucher M; Pikounis B; Xanthoudakis S; Roy S; Rigby M; Zamboni R; Robertson GS; Ng GY; Nicholson DW; Flückiger JP
Br J Pharmacol; 2004 Feb; 141(4):689-97. PubMed ID: 14744804
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system.
Griffin G; Wray EJ; Tao Q; McAllister SD; Rorrer WK; Aung MM; Martin BR; Abood ME
Eur J Pharmacol; 1999 Jul; 377(1):117-25. PubMed ID: 10448934
[TBL] [Abstract][Full Text] [Related]
17. Role of CB2 receptors in neuroprotective effects of cannabinoids.
Fernández-Ruiz J; Pazos MR; García-Arencibia M; Sagredo O; Ramos JA
Mol Cell Endocrinol; 2008 Apr; 286(1-2 Suppl 1):S91-6. PubMed ID: 18291574
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptor 2 activation restricts fibrosis and alleviates hydrocephalus after intraventricular hemorrhage.
Tan Q; Chen Q; Feng Z; Shi X; Tang J; Tao Y; Jiang B; Tan L; Feng H; Zhu G; Yang Y; Chen Z
Brain Res; 2017 Jan; 1654(Pt A):24-33. PubMed ID: 27769788
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid system in Huntington's disease.
Pazos MR; Sagredo O; Fernández-Ruiz J
Curr Pharm Des; 2008; 14(23):2317-25. PubMed ID: 18781982
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V
Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
